---
title: "Pre-market hot trades in US stocks: Future Fintech pre-market down 8.96%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249771751.md"
description: "Future Fintech pre-market down 8.96%; Abivax SA pre-market up 492.30%; Wang & Lee pre-market up 105.53%; Anebulo Pharmaceuticals pre-market up 77.05%"
datetime: "2025-07-23T12:22:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249771751.md)
  - [en](https://longbridge.com/en/news/249771751.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249771751.md)
generator: "portal-rs"
---

# Pre-market hot trades in US stocks: Future Fintech pre-market down 8.96%

**Popular Pre-Market Trades in US Stocks**

Future Fintech is down 8.96% in pre-market trading. Based on recent key news:

1.  On June 9, rising US bond yields led to a decline in bond ETF prices, causing investors to exit the market, impacting fintech stocks.

2.  On June 10, Waymo's self-driving cars were damaged during protests in Los Angeles, reflecting the potential risks of social unrest for tech companies.

3.  On June 12, fintech concept stocks surged, with ZhaoRi Technology, HengYin Technology, and DongXin HePing hitting the daily limit, showing the market's emphasis on fintech.

**Top Gainers in Pre-Market US Stocks**

Abivax SA is up 492.30% in pre-market trading. Based on recent key news:

1.  On July 22, Abivax SA announced the postponement of its financial report for the first half of 2025, originally scheduled for August 11, now delayed to September 8. Nevertheless, the company reported preliminary cash and cash equivalents of approximately $71.4 million as of June 30. This news may raise market concerns about the company's financial health, leading to significant stock price fluctuations.

Wang & Lee is up 105.53% in pre-market trading. Based on recent important news:

1.  On June 24, Dongfang Caifu's trading volume exceeded 13.2 billion yuan, boosting market confidence and driving stock prices higher.

2.  On June 9, Hongxing Capital reported that small-cap stocks were active, with liquidity easing, contributing to rising stock prices.

3.  On May 16, the CSI 2000 Enhanced ETF rose by 21.17%, indicating an increase in market risk appetite and driving stock prices up.

Anebulo Pharmaceuticals is up 77.05% in pre-market trading. Based on recent key news:

1.  On July 23, Anebulo Pharmaceuticals announced the approval to terminate its common stock registration plan and approved a reverse stock split ratio of 1 for 2500 to 1 for 7500. This news led to a significant increase in stock prices.

2.  On July 23, the company's board approved a privatization plan proposed by the special committee of independent directors, further driving up stock prices.

3.  On July 23, the announcement that shareholders would receive $3.50 per pre-split share enhanced market confidence, pushing stock prices higher

### Related Stocks

- [FTFT.US](https://longbridge.com/en/quote/FTFT.US.md)

## Related News & Research

- [OXY: Strong Q3 cash generation advanced debt reduction and the >$4B annual cash flow goal by 2030](https://longbridge.com/en/news/305061493.md)
- [14 companies sold 108,247 Bitcoin in 2026, but here’s why it’s not what it looks like!](https://longbridge.com/en/news/305139945.md)
- [Is the Stock Market Going to Crash? Warren Buffett's Warning Is Hard to Ignore.](https://longbridge.com/en/news/305154637.md)
- [US SEC seeks to close Musk, Tesla settlement fund](https://longbridge.com/en/news/305073867.md)
- [How Investors May Respond To Alibaba (BABA) Dakar Olympics Cloud Deal](https://longbridge.com/en/news/305185166.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**